10-Q Filing

SRX HEALTH SOLUTIONS, INC. CIK: 1471727 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001185185-19-000067`
Period End Date	20181130
Filing Date	20190114
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	senz-20181130.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 38 Cash Flow Statement 55

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Convertible Notes, unamortized debt discounts (in Dollars)	`DebtInstrumentUnamortizedDiscount`	$752.99K	USD	Point-in-time
Convertible Notes, unamortized debt discounts (in Dollars)	`DebtInstrumentUnamortizedDiscount`	-	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.17K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.60K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Inventory	`InventoryNet`	$9.40K	USD	Point-in-time
Inventory	`InventoryNet`	$9.40K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$209.08K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$33.00K	USD	Point-in-time
Total Assets	`Assets`	$209.08K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	52.41M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	79.68M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$106.44K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	52.41M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	79.68M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$61.71K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$20.28K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$29.81K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$2.32M	USD	Point-in-time
Accrued officer salary	`DueToOfficersOrStockholdersCurrent`	$132.00K	USD	Point-in-time
Accrued officer salary	`DueToOfficersOrStockholdersCurrent`	$140.00K	USD	Point-in-time
Convertible notes, net of unamortized debt discounts of $0 and $752,990, respectively	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes, net of unamortized debt discounts of $0 and $752,990, respectively	`ConvertibleNotesPayableCurrent`	$274.21K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$223.51K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.86M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized 52,412,342 and 79,683,842 shares issued and outstanding as of November 30, 2018 and August 31, 2018, respectively	`CommonStockValue`	$52.41K	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized 52,412,342 and 79,683,842 shares issued and outstanding as of November 30, 2018 and August 31, 2018, respectively	`CommonStockValue`	$79.68K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.33M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.55M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-190.51K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-2.65M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$33.00K	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$209.08K	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$214.00	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$27.00	USD	1 Quarter
Gross profit	`GrossProfit`	$187.00	USD	1 Quarter
Gross profit	`GrossProfit`	-	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$85.24K	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$147.52K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$85.24K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$147.52K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-147.52K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-85.06K	USD	1 Quarter
Interest expense	`InterestExpense`	$133.54K	USD	1 Quarter
Interest expense	`InterestExpense`	$136.93K	USD	1 Quarter
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	$472.27K	USD	1 Quarter
Gain on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$111.28K	USD	1 Quarter
Gain on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$314.02K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-25.64K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$652.74K	USD	1 Quarter
Net income (loss) before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$505.22K	USD	1 Quarter
Net income (loss) before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-110.70K	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-110.70K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$505.22K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	-	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$41.15K	USD	1 Quarter
Net income (loss) available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$464.07K	USD	1 Quarter
Net income (loss) available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-110.70K	USD	1 Quarter
Net income (loss) per share: basic (in Dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Net income (loss) per share: basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Net income (loss) per share: diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Net income (loss) per share: diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	78.41M	shares	1 Quarter
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	79.08M	shares	1 Quarter
Weighted average shares outstanding - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.41M	shares	1 Quarter
Weighted average shares outstanding - diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.77M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`IncomeLossFromContinuingOperations`	$-110.70K	USD	1 Quarter
Net income (loss)	`IncomeLossFromContinuingOperations`	$505.22K	USD	1 Quarter
Gain on exchange of debt and equity transaction	`OtherNonoperatingGainsLosses`	-	USD	1 Quarter
Gain on exchange of debt and equity transaction	`OtherNonoperatingGainsLosses`	$472.27K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$314.02K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$111.28K	USD	1 Quarter
Amortization of discount on convertible debt	`AmortizationOfDebtDiscountPremium`	$118.89K	USD	1 Quarter
Amortization of discount on convertible debt	`AmortizationOfDebtDiscountPremium`	$118.71K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-27.00	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Accrued officer salary	`IncreaseDecreaseInAccruedLiabilities`	$-8.00K	USD	1 Quarter
Accrued officer salary	`IncreaseDecreaseInAccruedLiabilities`	$24.00K	USD	1 Quarter
Interest payable - related party	`IncreaseDecreaseInInterestPayableNet`	-	USD	1 Quarter
Interest payable - related party	`IncreaseDecreaseInInterestPayableNet`	$241.00	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-32.19K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$21.56K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-111.02K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-148.80K	USD	1 Quarter
CASH FLOWS FROM INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
CASH FLOWS FROM INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Cash paid for the purchase of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Cash paid for the purchase of common stock	`ProceedsFromIssuanceOfCommonStock`	$-27.27K	USD	1 Quarter
Proceeds from notes payable - related party	`ProceedsFromRelatedPartyDebt`	$35.50K	USD	1 Quarter
Proceeds from notes payable - related party	`ProceedsFromRelatedPartyDebt`	-	USD	1 Quarter
Repayments of notes payable - related party	`RepaymentsOfRelatedPartyDebt`	$75.00K	USD	1 Quarter
Repayments of notes payable - related party	`RepaymentsOfRelatedPartyDebt`	-	USD	1 Quarter
Proceeds from convertible debt	`ProceedsFromRepaymentsOfRelatedPartyDebt`	-	USD	1 Quarter
Proceeds from convertible debt	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$241.25K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-27.27K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$201.75K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-176.07K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$90.73K	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$92.17K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.60K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$92.17K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.60K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Interest paid	`InterestPaidNet`	-	USD	1 Quarter
Interest paid	`InterestPaidNet`	$950.00	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	-	USD	1 Quarter
Common stock issued for conversion of notes payable	`DebtConversionConvertedInstrumentAmount1`	-	USD	1 Quarter
Common stock issued for conversion of notes payable	`DebtConversionConvertedInstrumentAmount1`	$55.00K	USD	1 Quarter
Preferred Stock Series E issued for cancellation of convertible notes payable, accrued interest, Series B Preferred Stock and warrants	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$2.02M	USD	1 Quarter
Preferred Stock Series E issued for cancellation of convertible notes payable, accrued interest, Series B Preferred Stock and warrants	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	1 Quarter
Discount on Convertible Debt and Accrued Interest	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	1 Quarter
Discount on Convertible Debt and Accrued Interest	`DebtInstrumentConvertibleBeneficialConversionFeature`	$126.56K	USD	1 Quarter
Settlement of derivative	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.00M	USD	1 Quarter
Settlement of derivative	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$23.45K	USD	1 Quarter
Settlement of derivative	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.00M	USD	Point-in-time
Accrued preferred stock dividends	`DividendsPreferredStock`	-	USD	1 Quarter
Accrued preferred stock dividends	`DividendsPreferredStock`	$41.15K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.